Galux

About:

Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases.

Website: https://www.galux.co.kr

Top Investors: Kakao Brain, Dayli Partners

Description:

Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases using its AI-based drug design platform technologies.

Total Funding Amount:

5B KRW

Headquarters Location:

Dogokdong, Seoul-t'ukpyolsi, South Korea

Founded Date:

2020-01-01

Contact Email:

contact(AT)galux.co.kr

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-12-16

IPO Status:

Private

Industries: